In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...